ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

NCI Supercomputer Operations To Start In April

November 15, 1985

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

Center Directors To Rewrite 5-Year Plan With Little Staff Help

March 9, 1990

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009